Publications by authors named "Inna Chen"

Claim this Profile
I
Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis.
Dorte Lisbet Nielsen, Carsten Bogh Juhl, Inna Markovna Chen, Yinghong Wang, Ole Haagen Nielsen

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST.
Mette M Steiniche, Sidsel C Lindgaard, Inna M Chen, Julia S Johansen, Rikke F Andersen

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target.
Nicholas Willumsen, Kim Henriksen, Cecilie Bager, Anette T Hansen Selnø, Khaled E Mohamed, Inna M Chen

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom burden and quality of life in patients with pancreatic and peri-pancreatic cancer at admission to specialized palliative care: a nationwide register-based study in Denmark.
Thukirtha Chelliah, Inna Markovna Chen, Claus Wilki Fristrup, Mogens Groenvold, Mathilde Adsersen

Support Care Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.
Inna M Chen, Julia S Johansen, Susann Theile, Libbie M Silverman, Katherine R Pelz

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.
Inna M Chen, Julia S Johansen, Susann Theile, Libbie M Silverman, Katherine R Pelz

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay).
Louise Rolin, Charlotte Hald, Dorte Nielsen, Susann Theile, Anne Birgitte Christiansen, Inna M Chen

Eur J Oncol Nurs· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma.
Rasmus S Pedersen, Annika Hettich, Jeppe Thorlacius-Ussing, Lasse L Langholm, Marina Crespo-Bravo, Inna M Chen

BMC Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer.
Carolyn Hruban, Daniel C Bruhm, Inna M Chen, Shashikant Koul, Akshaya V Annapragada

Sci Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma.
Benjamin Stubbe, Malene P Stoico, Simone K Terp, Poul H Madsen, Søren Lundbye-Christensen, Inna M Chen

Front Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paired Comparison of Whole Genome Sequencing and Comprehensive Targeted Sequencing of Pancreatic Cancer Tissue.
Thea Amalie Hvidtfeldt, Tim Svenstrup Poulsen, Inna Markovna Chen, Louise Laurberg Klarskov, Estrid Høgdall

Anticancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling.
Maria Perez-Penco, Mikkel Byrdal, Lucia Lara de la Torre, Marta Ballester, Shawez Khan, Inna Markovna Chen

Cell Mol Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.
Dorte Lisbet Nielsen, Carsten Bogh Juhl, Ole Haagen Nielsen, Inna Markovna Chen, Joerg Herrmann

JAMA Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases.
Federica Genovese, Cecilie Bager, Peder Frederiksen, Dario Vazquez, Jannie Marie Bülow Sand, Inna M Chen

Matrix Biol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition of Online Adaptive Stereotactic Radiotherapy for Pancreatic Cancer From Magnetic Resonance-Guided Linear Accelerator (MR-Linac) to State-of-the-Art Cone-Beam Computed Tomography (CBCT).
Laura A Rechner, Mette Felter, Susanne Bekke, Susan Biancardo, Marianne F Rønjom, Inna M Chen

Cureus· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.
Alice Markussen, Julia S Johansen, Finn O Larsen, Susann Theile, Jane P Hasselby, Inna M Chen

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records.
Jessica Xin Hjaltelin, Sif Ingibergsdóttir Novitski, Isabella Friis Jørgensen, Troels Siggaard, Siri Amalie Vulpius, Inna M Chen

Elife· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy.
Astrid Z Johansen, Sif I Novitski, Jessica X Hjaltelin, Susann Theile, Mogens K Boisen, Inna M Chen

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer.
Daniele Campa, Manuel Gentiluomo, Angelika Stein, Mateus Nóbrega Aoki, Martin Oliverius, Inna Chen

Crit Rev Oncol Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01).
Louise Skau Rasmussen, Stine B Winther, Inna M Chen, Britta Weber, Lise Ventzel

BMC Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer.
Troels D Christensen, Emil Maag, Ole Larsen, Claus L Feltoft, Kaspar René Nielsen, Inna M Chen

JHEP Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.
Rasmus Erik Johansson Mortensen, Morten Orebo Holmström, Thomas Landkildehus Lisle, Jane P Hasselby, Gro L Willemoe, Inna M Chen

J Immunother Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma.
Neel I Nissen, Astrid Z Johansen, Inna M Chen, Christina Jensen, Emilie A Madsen

Front Mol Biosci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.
Troels D Christensen, Kasper Madsen, Emil Maag, Ole Larsen, Lars Henrik Jensen, Inna M Chen

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma.
Liva K Stuhr, Kasper Madsen, Astrid Z Johansen, Inna M Chen, Carsten P Hansen

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis